0

IN THIS ISSUE

Archives of Neurology

July 2012, Vol 69, No. 7
Basic View  |  Expanded View
About This Journal FREE
Topics:
Arch Neurol. 2012;69(7):809. doi:10.1001/archneur.69.7.809.
This Month in Archives of Neurology FREE
Topics:
Arch Neurol. 2012;69(7):813-814. doi:10.1001/archneurol.2011.1464.
The JAMA Network Journals:  New Names for the Archives Journals
Howard Bauchner, MD; Daniel M. Albert, MD, MS; Joseph T. Coyle, MD; Julie Ann Freischlag, MD; Wayne F. Larrabee, MD; Paul A. Levine, MD; Rita F. Redberg, MD, MSc; Frederick P. Rivara, MD, MPH; June K. Robinson, MD; Roger N. Rosenberg, MD
Topics: dermatology, internal medicine, languages, librarians, neurology, ophthalmology, otolaryngology, pediatrics, psychiatry, semantics, tablet dosage form, vision, surgery specialty, facial plastic surgery, neck surgery
Arch Neurol. 2012;69(7):817. doi:10.1001/archneurol.2012.1927.
JAMA Neurology 2013:  A New Beginning
Roger N. Rosenberg, MD
Topics: neurology
Arch Neurol. 2012;69(7):818. doi:10.1001/archneurol.2012.1837.
Cutting-edge Questions About CLIPPERS (Chronic Lymphocytic Inflammation With Pontine Perivascular Enhancement Responsive to Steroids)
B. Mark Keegan, MD, FRCPC; Sean J. Pittock, MD
Topics: pons, steroids, lymphocytic inflammation, chronic
Arch Neurol. 2012;69(7):819-820. doi:10.1001/archneurol.2012.1015.
Plasma Amyloid-β as a Predictor of Dementia and Cognitive Decline:  A Systematic Review and Meta-analysis
Alain Koyama, SM; Olivia I. Okereke, MD, SM; Ting Yang, MD; Deborah Blacker, MD, ScD; Dennis J. Selkoe, MD; Francine Grodstein, ScD
Includes: Supplemental Content
Topics: amyloid, dementia, amyloid beta-protein, cognitive impairment
Arch Neurol. 2012;69(7):824-831. doi:10.1001/archneurol.2011.1841.
Antioxidants for Alzheimer Disease:  A Randomized Clinical Trial With Cerebrospinal Fluid Biomarker Measures
Douglas R. Galasko, MD; Elaine Peskind, MD; Christopher M. Clark, MD; Joseph F. Quinn, MD; John M. Ringman, MD; Gregory A. Jicha, MD, PhD; Carl Cotman, PhD; Barbara Cottrell, BS; Thomas J. Montine, MD, PhD; Ronald G. Thomas, PhD; Paul Aisen, MD; for the Alzheimer's Disease Cooperative Study
Includes: CME
Topics: antioxidants, alzheimer's disease, biological markers, recombinant colony-stimulating factors, cerebrospinal fluid
Arch Neurol. 2012;69(7):836-841. doi:10.1001/archneurol.2012.85.
Long-term Outcomes of CLIPPERS (Chronic Lymphocytic Inflammation With Pontine Perivascular Enhancement Responsive to Steroids) in a Consecutive Series of 12 Patients
Guillaume Taieb, MD; Claire Duflos, MD; Dimitri Renard, MD; Bertrand Audoin, MD, PhD; Elsa Kaphan, MD; Jean Pelletier, MD, PhD; Nadège Limousin, MD; Christine Tranchant, MD, PhD; Stephane Kremer, MD; Jérome de Sèze, MD, PhD; Romain Lefaucheur, MD; David Maltête, MD, PhD; David Brassat, MD, PhD; Michel Clanet, MD, PhD; Patrice Desbordes, MD; Eric Thouvenot, MD, PhD; Laurent Magy, MD, PhD; Thierry Vincent, MD, PhD; Jean-Luc Faillie, MD; Nicolas de Champfleur, MD; Giovanni Castelnovo, MD; Sandrine Eimer, MD; Dominique Figarella Branger, MD, PhD; Emmanuelle Uro-Coste, MD, PhD; Pierre Labauge, MD, PhD
Includes: CME , Supplemental Content
Topics: magnetic resonance imaging, glucocorticoids, atrophy, pons, steroids, brain stem, mineralocorticoids, spinal cord, brain biopsy, lymphocytic inflammation, chronic
Arch Neurol. 2012;69(7):847-855. doi:10.1001/archneurol.2012.122.
Shapes of the Trajectories of 5 Major Biomarkers of Alzheimer Disease
Clifford R. Jack, MD; Prashanthi Vemuri, PhD; Heather J. Wiste, BA; Stephen D. Weigand, MS; Timothy G. Lesnick, MS; Val Lowe, MD; Kejal Kantarci, MD; Matt A. Bernstein, PhD; Matthew L. Senjem, MS; Jeffrey L. Gunter, PhD; Bradley F. Boeve, MD; John Q. Trojanowski, MD, PhD; Leslie M. Shaw, PhD; Paul S. Aisen, MD; Michael W. Weiner, MD; Ronald C. Petersen, MD, PhD; David S. Knopman, MD; for the Alzheimer's Disease Neuroimaging Initiative
Topics: positron-emission tomography, magnetic resonance imaging, alzheimer's disease, apolipoprotein e, biological markers, recombinant colony-stimulating factors, mini-mental state examination
Arch Neurol. 2012;69(7):856-867. doi:10.1001/archneurol.2011.3405.
Contribution of Cerebrospinal Fluid Thymosin β4 Levels to the Clinical Differentiation of Creutzfeldt-Jakob Disease
Maria Le Pera, PhD; Elena Urso, PhD; Teresa Sprovieri, PhD; Sabrina Bossio, PhD; Umberto Aguglia, MD; Ida Manna, PhD; Chiara Cupidi, MD; Tiziana Ferraro, PhD; Antonio Gambardella, MD; Antonio Qualtieri, PhD; Aldo Quattrone, MD
Topics: creutzfeldt-jakob disease, dementia, thymosin, cerebrospinal fluid
Arch Neurol. 2012;69(7):868-872. doi:10.1001/archneurol.2011.3558.
Progressive Gait Deterioration in Adolescents With Dravet Syndrome
Jill M. Rodda, PhD; Ingrid E. Scheffer, PhD, MBBS; Jacinta M. McMahon, BSc; Samuel F. Berkovic, MD; H. Kerr Graham, MD
Topics: gait, infantile severe myoclonic epilepsy
Arch Neurol. 2012;69(7):873-878. doi:10.1001/archneurol.2011.3275.
Preservation of Neurons of the Nucleus Basalis in Subcortical Ischemic Vascular Disease
San Jung, MD; Chris Zarow, PhD; Wendy J. Mack, PhD; Ling Zheng, MBBS, PhD; Harry V. Vinters, MD; William G. Ellis, MD; Scott A. Lyness, MA; Helena C. Chui, MD
Topics: ischemia, magnetic resonance imaging, vascular diseases, cell count, neurons, basal nucleus of meynert
Arch Neurol. 2012;69(7):879-886. doi:10.1001/archneurol.2011.2874.
Alterations in Brain Transition Metals in Huntington Disease:  An Evolving and Intricate Story
H. Diana Rosas, MD; Y. Iris Chen, PhD; Gheorghe Doros, PhD; David H. Salat, PhD; Nan-kuei Chen, PhD; Ken K. Kwong, PhD; Ashley Bush, MD, PhD; Jonathan Fox, PhD; Steven M. Hersch, MD, PhD
Includes: Supplemental Content
Topics: homeostasis, huntington's disease, metals, brain
Arch Neurol. 2012;69(7):887-893. doi:10.1001/archneurol.2011.2945.
Effect of Genetic Variation in LRRTM3 on Risk of Alzheimer Disease
Christiane Reitz, MD, PhD; Christopher Conrad, PhD; Katherine Roszkowski; Robert S. Rogers; Richard Mayeux, MD, MSc
Topics: alzheimer's disease, genetics
Arch Neurol. 2012;69(7):894-900. doi:10.1001/archneurol.2011.2463.
Age and Rate of Cognitive Decline in Alzheimer Disease:  Implications for Clinical Trials
Charles Bernick, MD; Jeffrey Cummings, MD; Rema Raman, PhD; Xiaoying Sun, MS; Paul Aisen, MD
Topics: alzheimer's disease, cognitive impairment, neuropsychiatric inventory
Arch Neurol. 2012;69(7):901-905. doi:10.1001/archneurol.2011.3758.
Error in Byline: in Heterogeneity of Coenzyme Q10 Deficiency: Patient Study and Literature Review
Topics: heterogeneity, coenzyme q10
Arch Neurol. 2012;69(7):886. doi:10.1001/archneurol.2012.1271.
Organization in Autism
Rajesh Kana, PhD; Alan Percy, MD
Topics:
Arch Neurol. 2012;69(7):906-907. doi:10.1001/archneurol.2011.3596.
A Serine Synthesis Defect Presenting With a Charcot-Marie-Tooth–Like Polyneuropathy
Aurélie Méneret, MD; Elsa Wiame, PhD; Cecilia Marelli, MD; Timothée Lenglet, MD; Emile Van Schaftingen, MD, PhD; Frédéric Sedel, MD, PhD
Topics: charcot-marie-tooth disease, polyneuropathies, serine
Arch Neurol. 2012;69(7):908-911. doi:10.1001/archneurol.2011.1526.
Exonic Deletions of FXN and Early-Onset Friedreich Ataxia
Mathieu Anheim, MD, PhD; Louise-Laure Mariani, MD; Patrick Calvas, MD, PhD; Emmanuel Cheuret, MD; Fabien Zagnoli, MD; Sylvie Odent, MD; Claire Seguela, BS; Cecilia Marelli, MD; Marlène Fritsch, BS; Jean-Pierre Delaunoy, PhD; Alexis Brice, MD, PhD; Alexandra Dürr, MD, PhD; Michel Koenig, MD, PhD
Topics: friedreich ataxia, cardiomyopathy, wheelchair
Arch Neurol. 2012;69(7):912-916. doi:10.1001/archneurol.2011.834.
The Brighter Side of Music in Dystonia
Maja Kojovic, MD; Isabel Pareés, MD; Anna Sadnicka, MD; Panagiotis Kassavetis, MD; Ignacio Rubio-Agusti, MD; Tabish A. Saifee, MRCP; Matteo Bologna, MD; John C. Rothwell, PhD; Mark J. Edwards, PhD; Kailash P. Bhatia, FRCP
Includes: Supplemental Content
Topics: dystonia, music
Arch Neurol. 2012;69(7):917-919. doi:10.1001/archneurol.2012.33.
4H Syndrome With Late-Onset Growth Hormone Deficiency Caused by POLR3A Mutations
Ana Potic, MD; Bernard Brais, MD, MPhil, PhD; Karine Choquet; Raphael Schiffmann, MD, MHSc; Geneviève Bernard, MD, MSc, FRCPC
Topics: mutation, somatotropin deficiency, leukodystrophy, hypomyelination
Arch Neurol. 2012;69(7):920-923. doi:10.1001/archneurol.2011.1963.
Ataxia and Weakness in a Young Woman
Shin Chien Beh, MD; Sharon Nations, MD; Juan M. Pascual, MD, PhD; Steven Vernino, MD, PhD
Topics: ataxia, asthenia
Arch Neurol. 2012;69(7):924-927. doi:10.1001/archneurol.2012.1207.
An Unusual Case of Lower Leg Weakness
Roland Brilla, MD, MPH; Newrhee Kim, MD
Topics: asthenia, lower leg
Arch Neurol. 2012;69(7):928-929. doi:10.1001/archneurol.2011.2433.
Atypical Cerebral Venous Thrombosis:  Magnetic Resonance Imaging and Spectroscopy Features
Duško Kozić, PhD; Vesna Njagulj, MD; Jelena Ostojić, PhD; Slobodan Sekulić, PhD; Marija Žarkov, PhD
Topics: magnetic resonance imaging, spectrum analysis, cerebral venous thrombosis, atypical
Arch Neurol. 2012;69(7):930-931. doi:10.1001/archneurol.2011.2542.
“Blinding” Empty Sella:  Can Lumbar Puncture Be Avoided?
Paolo Frassanito, MD; Pasquale De Bonis, MD; Carmela Grazia Caputo, MD; Annunziato Mangiola, MD; Angelo Pompucci, MD; Carlotta Ginevra Nucci, MD; Gianluca Trevisi, MD; Carmelo Anile, MD
Topics: empty sella, diagnostic spinal puncture
Arch Neurol. 2012;69(7):932-933. doi:10.1001/archneurol.2011.2137.
Eight-and-a-Half Syndrome:  A Rare Pontine Neuro-ophthalmologic Syndrome
Alon Skaat, MD; Ruth Huna-Baron, MD
Topics: pons
Arch Neurol. 2012;69(7):934-935. doi:10.1001/archneurol.2011.2185.
Acute and Emergent Events in Sleep Disorders
Gregory S. Carter, MD, PhD
Topics:
Arch Neurol. 2012;69(7):936. doi:10.1001/archneurol.2012.732.
Primary Central Nervous System Tumors: Pathogenesis and Therapy
Michael Weller, MD
Topics:
Arch Neurol. 2012;69(7):937. doi:10.1001/archneurol.2012.818.
Lack of Response to Pulse Cyclophosphamide in Neuromyelitis Optica:  Evaluation of 7 Patients
Denis B. Bichuetti, MD, PhD; Enedina M. Lobato Oliveira, MD, PhD; Fernanda de Castro Boulos, MD; Alberto A. Gabbai, MD, PhD
Topics: cyclophosphamide, neuromyelitis optica
Arch Neurol. 2012;69(7):938-939. doi:10.1001/archneurol.2012.545.
IDEAL for CCSVI Research
Jim A. Reekers, MD, PhD, EBIR
Topics: ethics, informed consent, helsinki declaration, multiple sclerosis, venous insufficiency, voice, medical research, off-label use
Arch Neurol. 2012;69(7):939-940. doi:10.1001/archneurol.2012.322.
IDEAL for CCSVI Research—Reply
Michael A. Williams, MD; Arun Venkatesan, MD, PhD
Topics: ethics, multiple sclerosis, ethics, research, clinical research
Arch Neurol. 2012;69(7):939-940. doi:10.1001/archneurol.2012.325.
Physical Activity and AD-Related Pathology
Hui-Xin Wang, PhD
Topics: physical activity, pathology
Arch Neurol. 2012;69(7):940-941. doi:10.1001/archneurol.2012.507.
Physical Activity and AD-Related Pathology—Reply
Susan Landau, PhD; William Jagust, MD
Topics: physical activity, pathology
Arch Neurol. 2012;69(7):940-941. doi:10.1001/archneurol.2012.510.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems